Matthew Riley - PAVmed Senior Relations
| PAVM Stock | USD 10.27 0.18 1.72% |
Executive
Matthew Riley is Senior Relations of PAVmed Inc
| Address | 360 Madison Avenue, New York, NY, United States, 10017 |
| Phone | 917 813 1828 |
| Web | https://www.pavmed.com |
PAVmed Management Efficiency
The company has return on total asset (ROA) of (0.3678) % which means that it has lost $0.3678 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1744 %, meaning that it created $0.1744 on every $100 dollars invested by stockholders. PAVmed's management efficiency ratios could be used to measure how well PAVmed manages its routine affairs as well as how well it operates its assets and liabilities. At this time, PAVmed's Return On Tangible Assets are very stable compared to the past year. As of the 17th of February 2026, Return On Assets is likely to grow to 1.23, while Return On Capital Employed is likely to drop 6.16. At this time, PAVmed's Other Current Assets are very stable compared to the past year. As of the 17th of February 2026, Non Current Assets Total is likely to grow to about 34.4 M, though Net Tangible Assets are likely to grow to (17.3 M).Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Sivan Ozeri | Inspira Technologies Oxy | N/A | |
| LLM JD | Aptevo Therapeutics | 56 | |
| Adi Nir | Inspira Technologies Oxy | N/A | |
| Hao Liu | Burning Rock Biotech | 52 | |
| Nathaniel Grawey | Tenon Medical | N/A | |
| Mike Hershkovitz | Inspira Technologies Oxy | N/A | |
| Mingze Yin | Advanced Biomed Common | 37 | |
| John Gillings | STRATA Skin Sciences | 50 | |
| Jay Sturm | STRATA Skin Sciences | 70 | |
| Steve Moscaret | Tenon Medical | N/A | |
| Meshira Greenberg | Inspira Technologies Oxy | N/A | |
| IFang Cheng | Advanced Biomed Common | 46 | |
| Yafit Tehila | Inspira Technologies Oxy | 45 | |
| Xiaozhi Hu | Burning Rock Biotech | 42 | |
| Kevin Williamson | Tenon Medical | 40 | |
| Scott Madel | Biomerica | N/A | |
| Xinru Mao | Burning Rock Biotech | N/A | |
| Wyatt Giest | Tenon Medical | N/A | |
| Shmuel Gov | STRATA Skin Sciences | 66 | |
Management Performance
| Return On Equity | 0.17 | ||||
| Return On Asset | -0.37 |
PAVmed Inc Leadership Team
Elected by the shareholders, the PAVmed's board of directors comprises two types of representatives: PAVmed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PAVmed. The board's role is to monitor PAVmed's management team and ensure that shareholders' interests are well served. PAVmed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PAVmed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Gordon, General VP | ||
| Lishan MD, Chairman CEO | ||
| Michael Parks, Vice Relations | ||
| Adrian Miller, VP Relations | ||
| Matthew Riley, Senior Relations | ||
| Deepika Lakhani, Chief VP | ||
| Shaun MBA, Executive COO | ||
| Brian MD, Chief Affairs | ||
| Victoria Lee, Senior Officer | ||
| Victoria MD, Senior Officer | ||
| Dennis CPA, CFO President |
PAVmed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PAVmed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | ||||
| Return On Asset | -0.37 | ||||
| Profit Margin | 106.72 % | ||||
| Operating Margin | (968.80) % | ||||
| Current Valuation | 43.13 M | ||||
| Shares Outstanding | 921.28 K | ||||
| Shares Owned By Insiders | 17.61 % | ||||
| Shares Owned By Institutions | 9.70 % | ||||
| Number Of Shares Shorted | 129.58 K | ||||
| Price To Earning | (6.39) X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Will Health Care Equipment & Supplies sector continue expanding? Could PAVmed diversify its offerings? Factors like these will boost the valuation of PAVmed. Anticipated expansion of PAVmed directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PAVmed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (12.00) | Revenue Per Share | Quarterly Revenue Growth (0.99) | Return On Assets | Return On Equity |
Understanding PAVmed Inc requires distinguishing between market price and book value, where the latter reflects PAVmed's accounting equity. The concept of intrinsic value - what PAVmed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push PAVmed's price substantially above or below its fundamental value.
It's important to distinguish between PAVmed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PAVmed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, PAVmed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.